Research Article: The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience
Introduction:
IgA nephropathy (IgAN) is one of the most common primary glomerulonephritides, especially in Asia, and it is a leading cause of end-stage renal disease [1,2,3]. The clinical and pathological manifestations of IgAN are variable, and therefore, the prognosis is diverse. According to previous studies, many factors can aid in predicting the prognosis of IgAN, such as hematuria [4], proteinuria, hypertension, renal function and pathological factors [5,6,7]. To date, the pathophysiological mechanism has remained…
Read more